Ars Asks: Share your shell and show us your tricked-out terminals!

Exposure therapy to the bash shell brought me to the tipping point, and I jumped ship to the Macintosh side of the house. It ...
ascopubs.org

LEAP-014: An open-label, randomized, phase 3 study of first-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma.

INTEGRATE IIb: A randomized phase III open label study of regorafenib + nivolumab versus standard chemotherapy in refractory advanced gastroesophageal cancer (AGOC). This is an ASCO Meeting Abstract ...
World Bank

Global Findex Database 2021 survey headline findings on the use of financial services

The goal of financial inclusion is for account owners to benefit from the use of accounts for digital payments, savings, and appropriate credit because such uses provide a range of positive benefits ...
The Motley Fool

The Largest Companies by Market Cap in May 2026

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close. Explore the world of large-cap stocks and learn how these can shape your portfolio.
ascopubs.org

Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: Final analysis from the phase 3 CheckMate 214 trial.

Combination casdatifan plus cabozantinib expansion cohort of phase 1 ARC-20 study in previously treated patients with clear cell renal cell carcinoma.
Fox Business

The Bottom Line

Dagen McDowell and Brian Brenberg will round out the business day programming from 6-7 PM EST with The Bottom Line taking on the hotly debated issues in the business and political world. They will ...